phase readout
saveNCT06190509: Assessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women With Recurrent Vulvovaginal Candidiasis: A Randomized Controlled Study
ACTIVE_NOT_RECRUITINGupdated 25m ago
community read0 votes
Sponsor: LimmaTech Biologics AG. Phase: PHASE1. Conditions: Recurrent Vulvovaginal Candidiasis
view source ↗
comments(0)
5-min edit window · permanent after that